Recursion is a clinical stage TechBio company focused on decoding biology to improve lives. Leveraging the Recursion OS platform, which generates one of the world's largest proprietary biological datasets, the company uses advanced machine-learning algorithms and massive experimental and computational scale to advance drug discovery in areas like rare diseases, immuno-oncology, and inflammation. Headquartered in Salt Lake City with offices globally, Recursion is driving innovation at the intersection of technology, biology, and chemistry.
Recursion is seeking an Executive Director of Clinical Development to lead program development in their oncology medicine portfolio. This role involves overseeing drug discovery, regulatory submissions, and collaboration with external experts to contribute to the company’s innovation and efficiency in clinical trials. The company's mission is to decode biology to radically improve lives through its Recursion OS platform.
Recursion is a clinical stage TechBio company focused on decoding biology to improve lives. Leveraging the Recursion OS platform, which generates one of the world's largest proprietary biological datasets, the company uses advanced machine-learning algorithms and massive experimental and computational scale to advance drug discovery in areas like rare diseases, immuno-oncology, and inflammation. Headquartered in Salt Lake City with offices globally, Recursion is driving innovation at the intersection of technology, biology, and chemistry.
Recursion